Sinovac Biotech Co., Ltd
Nasdaq SVA · Beijing, China
Works in GI & liver · Infectious disease · Neurology · Respiratory
Sinovac Biotech Co., Ltd is a clinical trial sponsor based in Beijing, China, listed as Nasdaq SVA. It has 19 active clinical trials with 23,063 planned participants, in GI & liver, Infectious disease, Neurology and Respiratory. Since 2021 it has completed 36 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq SVA
Pipeline · 19 active trials
| Stage | Trial | Status |
|---|---|---|
On the market · 0 products
No marketed products under this name.
Questions about Sinovac Biotech Co., Ltd
Sinovac Biotech Co., Ltd is lead sponsor of 19 active clinical trials on ClinicalTrials.gov, with 23,063 planned participants, in GI & liver, Infectious disease, Neurology, Respiratory. Since 2021 it has completed 36 trials and stopped 1 early.
Sinovac Biotech Co., Ltd is based in Beijing, China and is listed as Nasdaq SVA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Sinovac Biotech Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-02.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-25.
Approve Suite is not affiliated with Sinovac Biotech Co., Ltd.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.